Todd Foley - Profile and Investment Details

Investor Profile

Todd Foley is a Venture Capital, Private Equity Firm, Investment Partner based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology, CODA Biotherapeutics, Tetherex Pharmaceuticals, Motus Therapeutics, Astute Medical, Clinical Ink, iPierian, Cullinan Oncology, TriVascular, Frontier Medicines, Aktis Oncology, Entrada Therapeutics, Atopix Therapeutics, Trishula TherapeuticsAratana Therapeutics, Harpoon Therapeutics, Umoja Biopharma, Radius Health, Oncorus, Proteon Therapeutics, Rhythm Metabolic, ElevateBio, Valeritas, Werewolf Therapeutics, Repare Therapeutics, Semma Therapeutics, Nevro, Kalidex Pharmaceuticals, Chiasma, 23andMe, Selexys Pharmaceuticals Corporation, Iconic Therapeutics, Dyne Therapeutics, Blade Therapeutics, Theraclone Sciences, Vascular Pharmaceuticals, Celladon, Raze Therapeutics, Conatus Pharmaceuticals, Twentyeight-Seven Therapeutics, Amphivena Therapeutics, True North Therapeutics, SiO2 Medical Products, Cerecor, TCR2, arGEN-X, Triplet Therapeutics, NeoVista, Tizona Therapeutics, Sideris Pharmaceuticals, ReCode Therapeutics, BioIntervene, Rhythm Pharmaceuticals, ITeos Therapeutics, Orna Therapeutics, IOmx Therapeutics, Syndax Pharmaceuticals, . Over time, Todd Foley has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Todd Foley is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Health Care, Genetics, Life Science, Information Technology (IT), Biotechnology, Genomics, Developer Tools, Medical, Real Estate, Therapeutics, Media and Entertainment, Emergency Medicine, Pharmaceuticals may find it worthwhile to explore potential connections with Todd Foley, as their portfolio suggests a familiarity and interest in this area.

Understanding Todd Foley’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.